VistaPharm recalls
6 official recalls and safety alerts involving VistaPharm since 2022-01, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.
This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with VistaPharm or the relevant agency.
- 2023-12-06
US
VistaPharm LLC recalls Aminocaproic Acid Oral Solution, 0.25 grams/mL, Rx only, packaged in 8 Fl. Oz. (236.5 mL) HDPE bottles, Manufactured for: VistaPharm,…
Failed Excipient Specifications: high content of ethylene glycol (EG)
- 2023-11-15
US
VistaPharm LLC recalls Mycophenolate Mofetil for Oral Suspension, USP, 200 mg/mL, Rx Only, bottle, Manufactured for: VistaPharm, Inc., Largo, FL 33771, USA,…
Defective Container: The adaptor does not fit into the neck of the bottle after reconstitution with water.
- 2023-10-25
US
VistaPharm LLC recalls Sucralfate Oral Suspension, 1g per 10mL, 16 oz (414 mL) PET bottle (12 bottles per case), Rx Only, Manufactured and Distributed by:…
Microbial Contamination of Non-Sterile Products: identified as Bacillus cereus.
- 2023-09-20
US
VistaPharm LLC recalls Sucralfate Oral Suspension 1g per 10mL, FOR ORAL ADMINISTRATION ONLY (414 mL bottle), Rx Only, Manufactured and Distributed by:…
Superpotent/Subpotent single ingredient Drug: Out of Specification Assay results
- 2022-11-02
US
VistaPharm, Inc. recalls Pyridostigmine Bromide Oral Solution, USP 60 mg/5 mL Delivers 5 mL, packaged in 5mL unit-dose cup, Rx only, Dist. by: VistaPharm, NDC…
cGMP Deviations: Out of specification for assay of one of the preservative ingredients.
- 2022-01-26
US
VistaPharm, Inc. recalls Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04
Failed Stability Specifications
FDA · DrugVistaPharm, Inc.Nationwide within the United States including Puerto RicoOfficial notice →